Glycerin
- Product NDC
- 46122-221
- 11-digit product format
- 461220221
- Labeler code
- 46122
- Product ID
- 46122-221_4147d1ac-9ee0-6442-e063-6294a90a576f
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Glycerin
- Dosage form
- SUPPOSITORY
- Route
- RECTAL
- Labeler
- Amerisource Bergen/Good Neighbor Pharmacy
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2013-09-12
- Substance
- GLYCERIN
- Active strength
- 2.1 g/1
- Pharmacologic classes
- Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 46122-221-63 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 46122-221-71 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 46122-221-63 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 46122-221-71 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 46122-221-63 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 46122-221-71 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 46122-221-63 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 46122-221-71 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 46122-221-71 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 46122-221-63 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 46122-221-71 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 46122-221-63 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 46122-221-71 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 46122-221-63 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glycerin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GLYCERIN | 2.1 g/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| PDC6A3C0OX | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 583084 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e6a8914f-cfd9-4c72-abaa-22189bf0faef | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 46122-221-63 | 2025-07-02 | GNP Glycerin Supp. |
| 46122-221-63 | 2025-07-02 | GNP Glycerin Supp. |
| 46122-221-71 | 2025-07-02 | GNP Glycerin Supp. |
| 46122-221-71 | 2025-07-02 | GNP Glycerin Supp. |
| 46122-221-63 | 2025-01-30 | GNP Glycerin Supp. |
| 46122-221-63 | 2025-01-30 | GNP Glycerin Supp. |
| 46122-221-71 | 2025-01-30 | GNP Glycerin Supp. |
| 46122-221-71 | 2025-01-30 | GNP Glycerin Supp. |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 46122-221-63 | Glycerin | 25 in 1 JAR | SUPPOSITORY | 25 | 11 | |
| 46122-221-71 | Glycerin | 50 in 1 JAR | SUPPOSITORY | 50 | 11 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 46122-221-63 | EA - Each | 46122-221 | ef78bcd7-30bc-4df8-b7e5-bd3e8eb0978c | 1 | 2013-10-17 |
| 46122-221-71 | EA - Each | 46122-221 | 12ac563a-74be-4ff3-8d4d-a32a1c803335 | 1 | 2013-10-17 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| up and up fiber therapy | PSYLLIUM HUSK | TARGET CORPORATION | 956c48f8-c705-4a86-9866-c68a48ddeb6c | 2026-11-06 | Warnings | M007 |
| Sennosides | SENNOSIDES | REMEDYREPACK INC. | 3873abcd-8312-47d1-bccf-4265e1e32861 | 2026-11-06 | Warnings | M007 |
| up and up fiber therapy | PSYLLIUM HUSK | Target Corporation | 674753ee-1174-4c06-9ed3-a090b338a39e | 2026-11-06 | Warnings | M007 |
| up and up fiber therapy Natural Fiber | PSYLLIUM HUSK | Target Corporation | f8b1c831-6fd0-4a58-9726-4e0f986c8084 | 2026-11-06 | Warnings | M007 |
| up and up fiber therapy | CALCIUM POLYCARBOPHIL | Target Corporation. | e5473950-06f4-4ea4-975b-3ac94957e776 | 2026-11-06 | Warnings | M007 |
| Target Fiber Laxative | PSYLLIUM HUSK | TARGET CORPORATION | a581116a-392d-4ac3-ae15-4318506a7b2a | 2026-11-05 | Warnings | M007 |
| up and up gentle laxative | BISACODYL | Target Corporation | 4a29dc2b-b68f-471b-a84e-4a5096aa3748 | 2026-11-05 | Warnings | M007 |
| Metamucil Therapy for regularity | PSYLLIUM HUSK | The Procter & Gamble Manufacturing Company | a9824f73-5ea2-4a65-a926-3a57561441b8 | 2026-11-04 | Warnings | M007 |
| Colon Detox | DOCUSATE SODIUM AND SENNOSIDES | OPMX LLC | 0a4d3265-080c-d2ed-e063-6394a90adbee | 2026-11-04 | Warnings | M007 |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-11-04 | Warnings | M007 |
| Fiber Caplets | CALCIUM POLYCARBOPHIL | SAFEWAY | 08e2e8b0-90b3-48d6-a72a-40688c74771a | 2026-11-03 | Warnings | M007 |
| citroma | MAGNESIUM CITRATE | Old East Main Co. | 9b3b6cea-ab83-4b7c-a425-fd0ac7df426c | 2026-11-02 | Warnings, Adverse reactions | M007 |
| Gentle Laxative Stimulant Laxative | BISACODYL | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | bcd3c07d-bd83-4452-9736-35c85db30c15 | 2026-10-29 | Warnings | M007 |
| Quality Choice | CALCIUM POLYCARBOPHIL | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | f1e69c65-c1b0-459f-9a12-b1a92b90036b | 2026-10-29 | Warnings | M007 |
| CDMA Fiber Therapy | METHYLCELLULOSE | CHAIN DRUG MARKETING ASSOCIATION | 62bbcaf2-1d0c-485f-9159-685700aa3418 | 2026-10-29 | Warnings | M007 |
| citroma | MAGNESIUM CITRATE | Old East Main Co. | 51ed515b-cc51-4ea1-b612-090476135005 | 2026-10-29 | Warnings, Adverse reactions | M007 |
| Quality Choice Fiber Laxative | PSYLLIUM HUSK | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 2ee637c4-c4c6-4a24-ae99-612205afd592 | 2026-10-29 | Warnings | M007 |
| Magnesium Citrate | EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | 4 Visions LLC | 5eeb0d66-06c7-7789-e063-6394a90aaff4 | 2026-10-28 | Warnings | M007 |
| Fiber Lax | CALCIUM POLYCARBOPHIL | PD-Rx Pharmaceuticals, Inc. | 730198a5-b6d9-4fc7-b053-a7c65a93c540 | 2026-10-27 | Warnings | M007 |
| Senna S | DOCUSATE SODIUM AND SENNOSIDES | Marlex Pharmaceuticals Inc | 9c87759f-3856-4f30-b5ea-4b37ed90f18c | 2026-10-27 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 583084 | glycerin 2.1 GM Adult Rectal Suppository | PSN | e6a8914f-cfd9-4c72-abaa-22189bf0faef | 11 |
| 583084 | glycerin 2100 MG Rectal Suppository | SCD | e6a8914f-cfd9-4c72-abaa-22189bf0faef | 11 |
| 583084 | glycerin 2.1 GM Rectal Suppository | SY | e6a8914f-cfd9-4c72-abaa-22189bf0faef | 11 |
| 583084 | glycerin 82.5 % Adult Rectal Suppository | SY | e6a8914f-cfd9-4c72-abaa-22189bf0faef | 11 |
| 583084 | glycerin 2.1 GM Adult Rectal Suppository | PSN | 89b5d376-f8c6-4c86-9dd8-67d047d0d45b | 1 |
| 583084 | glycerin 2100 MG Rectal Suppository | SCD | 89b5d376-f8c6-4c86-9dd8-67d047d0d45b | 1 |
| 583084 | glycerin 2.1 GM Rectal Suppository | SY | 89b5d376-f8c6-4c86-9dd8-67d047d0d45b | 1 |
| 583084 | glycerin 82.5 % Adult Rectal Suppository | SY | 89b5d376-f8c6-4c86-9dd8-67d047d0d45b | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 46122-221-63 | 46122022163 | 25 SUPPOSITORY in 1 JAR (46122-221-63) | 25 suppository | 2013-09-12 | 0000-00-00 | No | No | Current |
| 46122-221-71 | 46122022171 | 50 SUPPOSITORY in 1 JAR (46122-221-71) | 50 suppository | 2013-09-12 | 0000-00-00 | No | No | Current |